Frederik Harving

Frederik Harving is a Clinical Teacher at Aalborg University Hospital within the Faculty of Medicine, Department of Pathology, Aalborg University. He is an active clinician and researcher specializing in metabolic imaging, renal pathology, and molecular aspects of kidney disease and cancer metastasis.

His research interests include the application of hyperpolarized ¹³C-pyruvate MRI for early detection of kidney fibrogenesis, the role of n-3 polyunsaturated fatty acids in end-stage renal disease, and rare oncological phenomena such as symbiotic lymph node metastases. His work bridges clinical pathology with advanced imaging and metabolic biochemistry.

The recent publications highlight a strong trend in translational medical research, particularly in non-invasive diagnostics for kidney disease and metabolic profiling. His contributions span radiology, nephrology, oncology, and nutritional biochemistry, demonstrating interdisciplinary expertise.

Frederik Harving has contributed to significant research output with publications in peer-reviewed journals such as Investigative Radiology, BMJ Case Reports, and Clinical Nephrology. His 2015 article on fatty acids and adiponectin has received 14 citations, including policy citations, and his 2024 study on metabolic MRI has already gained attention in clinical guidelines and news media.

He collaborates with researchers across disciplines, including radiologists, nephrologists, and metabolic scientists. His recent press coverage titled "Ny teknologi kan afsløre nyresygdomme tidligere end standard-metoder" (New technology can detect kidney diseases earlier than standard methods) highlights the clinical relevance and impact of his work. Though no formal advising or grant information is available, his active publication record and media engagement suggest ongoing research involvement.

Frederik Harving is part of a collaborative network focused on metabolic imaging and renal pathology, working closely with experts such as Christian Laustsen and Alexander Wanders. His research is integrated into clinical innovation pathways, with one study already referenced in clinical guideline sources, indicating translational impact.